Among 360 regular cannabis users in Switzerland, only depression and ADHD symptom severity predicted how often and how much cannabis people used after adjusting for other factors.
Psychiatrists, addiction counselors, primary care providers, and researchers studying self-medication patterns.
What the researchers found
After adjusting for age, gender, education, alcohol, and other substance use, only depression and ADHD remained significantly associated with both frequency (p=.006, p=.034) and quantity (p=.037, p=.019). Anxiety and psychosis associations disappeared after adjustment.
Why it matters
The selective association with depression and ADHD but not anxiety or psychosis suggests specific self-medication patterns, with implications for which psychiatric populations need targeted cannabis screening.
The numbers in context
360 participants. Depression predicted frequency (p=.006) and quantity (p=.037). ADHD predicted frequency (p=.034) and quantity (p=.019). Anxiety and psychosis: not significant after adjustment.
How the study worked
Cross-sectional study of 360 regular cannabis users in Basel, Switzerland, using validated measures (PHQ-9, GAD-7, ASRS, IRAOS, CUDIT-R). Multiple regression adjusted for demographics and substance use.
What this study cannot tell us
Cross-sectional design. Self-selected sample interested in regulated cannabis access. Self-report measures. Swiss sample may not generalize globally.
How to read the evidence
Well-powered sample with validated measures and appropriate adjustment, though cross-sectional design limits causal claims.
When this study was published
2024 publication.
The bigger picture
The self-medication hypothesis operates selectively. If people with depression and ADHD specifically escalate use, targeted interventions for these groups could be more effective than general cannabis education.
Questions still open
- Would treating depression and ADHD reduce cannabis consumption?
- Why do anxiety symptoms not independently predict cannabis use after adjustment?
Common questions
Do people with mental health problems use more cannabis?
Is cannabis self-medication for ADHD?
Read the original research
Cannabis use and its association with psychopathological symptoms in a Swiss adult population: a cross-sectional analysis.
Frontiers in public health, 12, 1356988
Citation
Mosandl, Christoph Felix; Baltes-Flückiger, Lavinia; Kronschnabel, Jens; Meyer, Maximilian; Guessoum, Adrian; Herrmann, Oliver; Vogel, Marc; Walter, Marc; Pichler, Eva-Maria. (2024). Cannabis use and its association with psychopathological symptoms in a Swiss adult population: a cross-sectional analysis.. Frontiers in public health, 12, 1356988. https://doi.org/10.3389/fpubh.2024.1356988
Explore the wider topic
- LGBTQ+ and Cannabis: Higher Use Rates and Recovery
- Cannabis-Induced Psychosis: What It Is, Who's at Risk, and What to Do
- BetterHelp, Cerebral, and Online Therapy: Honest Review
- Quitting Weed with ADHD: Why It Is Harder and What Actually Helps
- Quitting Weed with Depression: What You Need to Know
- Quitting Weed with PTSD: A Practical Guide
- Self-Medicating with Weed: Why It Works Until It Doesn't
- Weed and OCD: Self-Medicating Intrusive Thoughts
- Weed and PTSD: What the Research Actually Shows
- Weed and Childhood Trauma: ACEs, Self-Medication, and the Path to Real Healing
- Weed and Suicidal Thoughts: What You Need to Know